Max Robotics — Global Service Robot Directory + US Certification

About

Thomas Grevesse is a pioneering figure in the field of organ-on-a-chip technology, with a research focus on microphysiological systems, tissue engineering, and automated bioinstrumentation. His most impactful contribution is the development of the "Interrogator," a robotic platform that enables automated fluidic coupling, culture, and real-time microscopic imaging of up to ten vascularized organ chips simultaneously. This work, detailed in his 2019 paper, revolutionized how researchers model human physiology by allowing multiple organ systems—such as liver, lung, and heart—to be linked in a single experiment, mimicking systemic interactions. His 2020 follow-up study on robotic fluidic coupling has garnered over 400 citations, underscoring its significance in advancing drug testing and disease modeling. Grevesse’s innovations reduce manual handling, increase throughput, and enhance reproducibility, making complex multi-organ experiments feasible. His achievements have positioned him as a leader in the integration of robotics with biology, offering a powerful tool for personalized medicine and toxicology studies.